In this retrospective study, we present evidence for a favorable clinical outcome to CAR-T cell therapy in DLBCL patients carrying a germline CTLA4 rs231775-encoding alanine at amino acid position 17 of the CTLA4 protein. Here, CTLA4 is linked to diffuse large B-cell lymphoma.